Uniqure NV (NASDAQ:QURE)

38.85
Delayed Data
As of Oct 28
 -3.33 / -7.89%
Today’s Change
34.38
Today|||52-Week Range
76.69
-45.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.9B

Company Description

uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Contact Information

uniQure NV
Paasheuvelweg 25a
Amsterdam Noord-holland 1105 BP
P:(120) 240-6000
Investor Relations:

Employees

Shareholders

Other institutional43.78%
Mutual fund holders38.39%
Individual stakeholders12.15%

Top Executives

Matt KapustaCEO, Chief Financial Officer & Executive Director
Alex KutaExecutive Vice President-Operations
Robert GutExecutive Director & Chief Medical Officer
Jonathan GarenChief Business Officer
Ricardo DolmetschPresident-Research & Development